Telomerase-reverse-transcriptase (TERT) promoter mutations have been recently described in tumors. In the present large series, TERT mutations were found in 12% of papillary thyroid cancers (PTCs) and in 14% of follicular thyroid cancers (FTCs), and were found to significantly correlate with older age at diagnosis and poorer outcome. Interestingly, the prognostic value of TERT mutations resulted to be significantly stronger than that of BRAF(V600E). Moreover, the outcome was not different among tumors with isolated TERT mutation and those with coexistent mutations (TERT/BRAF in PTCs or TERT/RAS in FTCs). TERT rs2853669 polymorphism was found in 44.4% of tumors. At WB, TERT was significantly more expressed in tumors than in normal samples, being the highest levels of expression recorded in TERT mutated cases. At IHC, in tumors and in metastatic lymph-nodes TERT staining was significantly higher in the cytoplasm than in the nucleus, whereas in normal tissue the degree of staining did not differ in the two cellular compartments. In conclusion, TERT mutations were shown to strongly correlate with a poorer outcome in differentiated thyroid tumors, and neither BRAF nor RAS mutation were found to confer an additional effect in the disease persistence. TERT protein was found to be more expressed in neoplastic than in normal tissues, and to display a different cellular localization, suggesting that it could contribute to thyroid cancer progression by mechanisms taking place in the cytoplasm.

Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization / Muzza, Marina; Colombo, Carla; Rossi, Stefania; Tosi, Delfina; Cirello, Valentina; Perrino, Michela; De Leo, Simone; Magnani, Elisa; Pignatti, Elisa; Vigo, Beatrice; Simoni, Manuela; Bulfamante, Gaetano; Vicentini, Leonardo; Fugazzola, Laura. - In: MOLECULAR AND CELLULAR ENDOCRINOLOGY. - ISSN 0303-7207. - STAMPA. - 399:(2015), pp. 288-295. [10.1016/j.mce.2014.10.019]

Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization

Magnani, Elisa;PIGNATTI, Elisa;SIMONI, Manuela;
2015-01-01

Abstract

Telomerase-reverse-transcriptase (TERT) promoter mutations have been recently described in tumors. In the present large series, TERT mutations were found in 12% of papillary thyroid cancers (PTCs) and in 14% of follicular thyroid cancers (FTCs), and were found to significantly correlate with older age at diagnosis and poorer outcome. Interestingly, the prognostic value of TERT mutations resulted to be significantly stronger than that of BRAF(V600E). Moreover, the outcome was not different among tumors with isolated TERT mutation and those with coexistent mutations (TERT/BRAF in PTCs or TERT/RAS in FTCs). TERT rs2853669 polymorphism was found in 44.4% of tumors. At WB, TERT was significantly more expressed in tumors than in normal samples, being the highest levels of expression recorded in TERT mutated cases. At IHC, in tumors and in metastatic lymph-nodes TERT staining was significantly higher in the cytoplasm than in the nucleus, whereas in normal tissue the degree of staining did not differ in the two cellular compartments. In conclusion, TERT mutations were shown to strongly correlate with a poorer outcome in differentiated thyroid tumors, and neither BRAF nor RAS mutation were found to confer an additional effect in the disease persistence. TERT protein was found to be more expressed in neoplastic than in normal tissues, and to display a different cellular localization, suggesting that it could contribute to thyroid cancer progression by mechanisms taking place in the cytoplasm.
27-ott-2014
399
288
295
Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization / Muzza, Marina; Colombo, Carla; Rossi, Stefania; Tosi, Delfina; Cirello, Valentina; Perrino, Michela; De Leo, Simone; Magnani, Elisa; Pignatti, Elisa; Vigo, Beatrice; Simoni, Manuela; Bulfamante, Gaetano; Vicentini, Leonardo; Fugazzola, Laura. - In: MOLECULAR AND CELLULAR ENDOCRINOLOGY. - ISSN 0303-7207. - STAMPA. - 399:(2015), pp. 288-295. [10.1016/j.mce.2014.10.019]
Muzza, Marina; Colombo, Carla; Rossi, Stefania; Tosi, Delfina; Cirello, Valentina; Perrino, Michela; De Leo, Simone; Magnani, Elisa; Pignatti, Elisa; Vigo, Beatrice; Simoni, Manuela; Bulfamante, Gaetano; Vicentini, Leonardo; Fugazzola, Laura
File in questo prodotto:
File Dimensione Formato  
162.pdf

Accesso riservato

Descrizione: Articolo principale
Tipologia: Versione pubblicata dall'editore
Dimensione 1.15 MB
Formato Adobe PDF
1.15 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1063411
Citazioni
  • ???jsp.display-item.citation.pmc??? 38
  • Scopus 92
  • ???jsp.display-item.citation.isi??? 82
social impact